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During the past 15 years, the curriculum content for nonprescription medication and self-care 
therapeutics has expanded significantly. Self-care courses ranging from standalone, required courses to 
therapeutic content and skills laboratories, have evolved in colleges and schools of pharmacy to 
accommodate rapid changes related to nonprescription medications and to meet the needs of students. The 
design of and content delivery methods used in self-care courses vary among institutions. Teaching 
innovations such as team-based learning, role playing/vignettes, videos, and social media, as well as 
interdisciplinary learning have enhanced delivery of this content. Given that faculty members train future 
pharmacists, they should be familiar with the new paradigms of Nonprescription Safe Use Regulatory 
Expansion (NSURE) Initiative, nonprescription medications for chronic diseases, and the growing trends 
of health and wellness in advancing patient-care initiatives. This paper reviews the significant changes 
that may be impacting self-care curriculums in the United States  
Keywords: self-care, nonprescription medications, pharmacy education 
 
 
INTRODUCTION  
In 2012, the Nonprescription Medicines Academy (NMA) and the Self-Care Institute (SCI) 
celebrated their 15 and 10 year anniversaries, respectively. These anniversaries have encouraged 
reflection on the vast changes in self-care education, the growing role of nonprescription medicine in 
health care, and the value of faculty development programming to support faculty members who teach 
self-care in the pharmacy curriculum. During the past 15 years, the curriculum content for nonprescription 
medication and self-care therapeutics has expanded significantly. New nonprescription products, 
formulation modifications, safety concerns, and regulatory changes are impacting the evolving 
responsibilities of the pharmacist in self-care. With these changes, self-care courses also transform to 
include innovative teaching strategies as pharmacy students needs in this area become greater. This paper 
reviews the significant changes that may be impacting self-care curriculums in the United States. 
 
MILESTONES IN SELF-CARE OVER THE PAST 15 YEARS 
The nonprescription medication marketplace has grown extensively over the last 15 years. There 
are now more than 300,000 nonprescription medication products in 80 therapeutic classes marketed in the 
United States.1 This number has increased twofold since 2001 when just more than 100,000 
nonprescription medication products were on the market.2 A contributing factor to this increase is the 
recent rise in prescription medications now being available in nonprescription formulation (prescription to 
nonprescription switches), allowing medications that once required a prescription to be purchased without 
one. 
 During this timeframe, more than 35 products have come to the market either directly as a 
nonprescription medication or as a prescription to nonprescription switch. Table 1 highlights major 
changes to the nonprescription market during this timeframe.3,4 In 2002, loratadine (Claritin) became the 
first second-generation antihistamine available without a prescription. This prescription to 
nonprescription switch revolutionized the treatment of seasonal and perennial allergies by providing the 
first non-sedating antihistamine option. It also changed managed-care pharmacy, as many pharmacy-
benefit managers removed second-generation antihistamines from their formularies, forcing patients to 
use nonprescription medications as an initial therapeutic approach.  
In 2003, omeprazole (Prilosec OTC) became the first proton-pump inhibitor (PPI) available 
without a prescription. This prescription to nonprescription switch transformed the treatment of frequent 
heartburn by providing patients an option beyond antacids and H2-antagonists. It also allowed pharmacy-
benefit managers to implement step-therapy in their formularies, requiring patients to first use 
nonprescription omeprazole before trying prescription PPIs.  
In 2006, levonorgestrel (Plan B) became the first dual-labeled product, ie, available as both a 
prescription and nonprescription, depending on patient age. Emergency contraception available without a 
prescription provides thousands of women increased access, which will be further increased now that the 
age limit has been lifted.5 In 2007, orlistat (alli) became the first nonprescription weight-loss medication 
to receive approval by the Food and Drug Administration (FDA). This prescription to nonprescription 
switch capitalized on the growing health and wellness trend, providing patients a weight-loss option that, 
when combined with diet and physical activity, is safer than stimulant products. This movement has 
expanded further to include chronic conditions with the recent 2013 switch of oxybutynin patch to treat 
overactive bladder and triamcinolone acetonide for nasal allergy symptoms.6,7   
During the past 15 years, dozens of safety concerns have been raised and regulations have been 
instituted in the nonprescription medicine area. In 2005, the Combat Methamphetamine Epidemic Act 
was passed. This federal statute placed restrictions on pseudoephedrine sales and access and implemented 
reporting requirements.7 States have passed additional laws regarding restrictions to pseudoephedrine. 
Another regulatory issue occurred a year later with the passage of the Dietary Supplement and 
Nonprescription Drug Consumer Protection Act. This act required manufacturers, packers, distributers, 
and retailers to record and report adverse events.8 Regulations requiring current Good Manufacturing 
Practices for dietary supplements became law in 2006. This ruling ensures the quality of supplements by 
setting guidelines related to the manufacturing, labeling, and holding of these products; however, it does 
not provide additional safety, effectiveness, and dissolution evidence that is greatly needed.9 In 2007, the 
FDA rejected the prescription to nonprescription switch of a statin for the third time.10 Pediatric cough 
and cold products were recalled, relabeled, and are still being investigated for appropriateness in children 
2-11 years old.11 Acetaminophen labeling and formulations for infants, children, and adults have also 
undergone changes to ensure safe usage.12  Historically, prescription to nonprescription changes have 
involved medications that treat acute problems (symptoms lasting less than 2 weeks). However, the most 
recent switches of 2013 are now dealing with more chronic issues and could increase the potential for 
further concerns in the future. 
Significant changes in growing therapeutic categories as well as regulatory and safety concerns 
have impacted content delivered in self-care curricula. Both the SCI and NMA have been at the forefront 
of providing the most up-to-date information regarding these products to assist self-care faculty members 
with the integration of this information into both classroom and experiential teaching.  The NMA 
Facebook page has been a resource highlighting these updates in nonprescription news, and editorial 
board members from SCI provide chapter updates through the American Pharmacists Association’s 
Handbook of Nonprescription Drugs.13,14  
 
SELF-CARE EDUCATION 
During this 15-year time period, there also have been great strides in self-care within pharmacy 
education. The blueprint for the North American Pharmacists Licensure Examination (NAPLEX) was 
revised in 2005 to recognize the importance of nonprescription medicines, eliminating any distinction of 
importance between prescription and nonprescription medicines.15,16 The Journal published a 
Nonprescription Medicines and Self-Care theme issue in 2006, which featured several articles reinforcing 
the importance of self-care instruction. Part of this supplement identifies the pharmacist as the “only 
health professional who receives in-depth formal education and skill development in nonprescription drug 
therapy.”17 Shortly after this publication, the 2007 Accreditation Standards and Guidelines for the 
Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree stated that education 
relating to nonprescription medicines and self-care should be incorporated throughout the pharmacy 
curriculum, including introductory and advanced pharmacy practice experiences (IPPEs and APPEs).  
Guidance regarding the incorporation of self-care and nonprescription medicines into the pharmacy 
curriculum can be found in Appendix B, C, and D of the accreditation standards.18 Establishment of the 
American Association of Colleges of Pharmacy Self-Care Therapeutics/Nonprescription Medicines 
Special Interest Group (SIG) soon followed, providing another opportunity for self-care faculty to 
network, learn, and promote the scholarship of self-care education.19 Practicing pharmacists are also 
enhancing their self-care knowledge through continuing education opportunities such as the National 
Alliance of State Pharmacy Associations partnership with NMA to conduct Student Pharmacists Self-
Care Championships, which are held nationwide at annual state pharmacy conventions.20 These events are 
often led by local self-care faculty members as student teams compete in an event similar to a quiz bowl, 
during which they answer questions developed by NMA faculty members and which may involve 
continuing education credit. 
Self-care instruction is incorporated into the pharmacy curriculum in many ways. Some colleges 
and schools require it to be a standalone course, while others offer it as an elective. Still others may 
integrate the curriculum within existing therapeutics courses, simulation laboratories, or in IPPEs and 
APPEs.21 Various methods have been used to assist with self-care instruction in the classroom. Although 
lecture is still the most common mode of delivery, active-learning strategies appear to be a growing 
trend.22-24 Use of active-learning strategies in the classroom to support and develop a student’s ability to 
critically think and problem solve has been well established. There are several active-learning strategies 
that could be incorporated into the self-care curriculum from think-pair-share, one-minute reflection, or 
the muddiest point exercises; to more complex activities, such as role-playing, problem-based learning, 
case-based learning, and team-based learning. Additionally, there are technology-based active-learning 
activities, such as audience-response systems, videos, and social media, that can be incorporated to 
engage students in their learning. Several strategies discussed herein have been incorporated into NMA 
and SCI programming to assist and encourage faculty members to use various methods to enhance the 
delivery of self-care instruction. Faculty members are regularly invited to present poster/platform 
presentations and roundtable discussions to share their innovations in teaching.25,26 Faculty resources, 
including complex cases, assessment questions, grading tools, syllabi, active-learning techniques and 
strategies are available on the NMA website. The SCI also makes available resources from the annual 
meetings and editors continually provide updates through the APhA Library and Pharmacy Today 
articles. 
Two key learning components in the self-care curriculum are effective communication and 
patient assessment. The pharmacist must be able to effectively and efficiently ask the patient pertinent 
questions to determine the problem, the most bothersome symptoms, other medical conditions, and 
medications being used. Role-playing and vignettes are strategies that can be used to teach these skills. 
Scenarios can be created and the students can then act out what they would do for the patient. The faculty 
member can assess and evaluate the students not only on the process used (ie, communication skills and 
critical thinking) but also on their nonprescription medication knowledge. Role-playing activities wherein 
students engage in patient consultations also can be used to develop social emotional competences.27 
There is a growing body of evidence to support the use of this type of active learning in the classroom to 
meet the educational needs of future pharmacists and ensure they develop necessary skills.28-35 
Team-based learning (TBL) is a type of collaborative learning that shifts the focus of classroom 
time from a lecture format to the application of key concepts. This type of learning is sometimes called 
the “flipped classroom” because it requires students to acquire the initial content through readings, online 
presentations, or other resources prior to class. At the beginning of class, students are assessed on the pre-
class requirements by means of a Readiness Assurance Technique (RAT). Both individual assessments (I-
RAT) and group assessments (G-RAT) are completed at the beginning of class. Having both RATs holds 
the students accountable for being prepared for class.  Following the completion of both RATs, the 
remainder of the class is spent on application-type activities, such as case discussions, ethical dilemmas, 
and pro/con discussions. Use of TBL is emerging in the development and delivery of self-care 
therapeutics.36-39 
Pharmacy school curricula have expanded to incorporate YouTube projects and Facebook 
campaigns in self-care and public health courses. This strategy is intended to expand the skills and 
abilities of pharmacy students in reaching the community at large the community at large with succinct 
self-care messages. The purpose of these messages is to stress the safe use of nonprescription medications 
and to promote the role of pharmacists in assisting and educating patients regarding self-care products.40 
Example projects, course outcomes, and evidence of student impact have been presented at NMA, 
enabling other colleges and schools of pharmacy to consider adopting a similar approach in their courses. 
The use of YouTube for patient education is an area in which further research is needed to determine the 
impact that videos have on patients’ understanding of their medications, improving adherence, and 
reducing medications errors and adverse events. Social media content could be considered as labeling and 
advertisement of these products, which is under the jurisdiction of the FDA.41 FDA guidance and 
regulations regarding social media messaging will be an important statement for colleges and schools of 
pharmacy that are using media as an instructional tool to review and integrate into their curricula. 42  
 
THE FUTURE OF SELF-CARE  
Nonprescription Safe Use Regulatory Expansion (NSURE) Initiative 
In 2012, the FDA announced it was looking at ways to approve the use of prescription 
medications by making them available as nonprescription through conditions of safe use. Under the 
FDA’s NSURE Initiative, the “conditions of safe use” could include pharmacist interventions or 
innovative technologies. Manufacturers can submit an application to the FDA for review and 
consideration. The FDA states that this paradigm could address the public health problem of under-
treatment of common conditions.43,44 Other FDA considerations for this paradigm include: allowing some 
medication products that require an initial prescription to be available for refills without a prescription, 
with a condition of safe use for that purpose and permitting some drug products to be available by 
prescription and without a prescription simultaneously, with conditions of safe use. 
This potential new paradigm is important to pharmacists, as it would serve as an opportunity for 
them to communicate and collaborate with the medical community to improve team-based care; reconnect 
and refer into the healthcare system those patients who may have undertreated chronic conditions or may 
need expanded access to life-saving rescue medications; and leverage patients’ access to pharmacists to 
safely increase the availability of certain medications, as pursued by manufacturers for nonprescription 
approval as developed within this initiative.45  
Although the FDA is considering the NSURE Initiative, not all healthcare professions support 
this action. In June 2012, the American Medical Association House of Delegates adopted resolution 235, 
which was in opposition to the FDA’s Rx to OTC Paradigm Shift.46 The steering committee and editorial 
boards for NMA and SCI have incorporated regulatory issues such as NSURE into their programming 
when relevant so that self-care faculty members can share it with students in the classroom and with 
practicing pharmacists at the state level.   
  
Health and Wellness Initiatives 
As more Americans have become increasingly aware of their health, there is a growing trend 
toward disease prevention and maintaining healthy lifestyles. Although pharmacists have traditionally 
been available to offer advice and education on disease states, they are equally capable of offering advice 
and education on how to prevent disease through healthy lifestyles and information on nutritional 
supplementation, such as dietary supplements. 
Over the past 3 to 4 years, most pharmacy retailers are encouraging pharmacists to offer wellness 
services to their patients.47-50 These include blood pressure and cholesterol screenings, blood glucose 
testing, risk assessments for chronic obstructive pulmonary disease and diabetes, immunizations, and 
weight-loss management. Some pharmacies even offer organic foods and fresh produce while nutrition 
experts educate patients on the benefits of healthy, nutritious foods.  
Many insurance companies and employers are offering incentives for members to participate in 
wellness initiatives. The majority of services are offered free of charge to patients. Most of the financial 
benefits seen in pharmacies stem from increased sales of wellness products. Billing for pharmacy services 
not linked to a product, including wellness services, has traditionally been a challenge for pharmacists 
because they are not able to bill for cognitive services under their own National Provider Identification 
number but must collaborate with another provider or insurance company to gain reimbursement for 
services.  
As Americans take control of their health through wellness initiatives, the pharmacist’s role 
becomes increasingly more important in the overall well-being of our patients. SCI and NMA continue to 
play a key role in providing self-care educators resources for preparing the next generation of 
pharmacists. Just as self-care has become more preventative, SCI and NMA have followed this trend, 
consistently incorporating topics related to health, wellness, and disease prevention and expanding on 
nonpharmacological measures, appropriate use of dietary supplements, and the growing role of home-
based health-monitoring devices. Although current legislation does not allow for full reimbursement of 
services, we anticipate that future healthcare reform will give pharmacists the opportunity to be engaged 
in health and wellness initiatives. 
 
CONCLUSION 
Self-care has evolved and will continue to grow as patients become more empowered and 
medications that once were available only by prescription become more readily available without a 
prescription. Pharmacists have a vital role in triaging and assisting patients in the selection of the most 
appropriate treatment option. As self-care continues to expand, it is imperative that pharmacy colleges 
and schools meet the challenges of educating future pharmacists to effectively assist patients in this area. 
Although changes have been made in self-care curricula, there is a great need for outcomes research to 
evaluate how well this challenge is being met.   
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 Table 1. Approvals for Prescription Medications to be Available as Nonprescription Medications, 1997-2013  
Year 
No. of New 
Approvals 
for Prescription to 
Nonprescription 
Switches Ingredients Product Examples (Manufacturers) 
1997 6 cromolyn sodium, tioconazole, 
loperamide/simethicone, triclosan, 
ketoconazole, minoxidil 
Nasalcrom (McNeil Consumer), Vagistat-1 
(Bristol-Meyers Squibb), others, Imodium 
Advanced (McNeil Consumer), Total 
(Colgate – Palmolive), Nizoral (Johnson & 
Johnson), Rogaine Extra Strength for Men 
(Johnson & Johnson) 
1998 1 miconazole nitrate Monistat 3 (Advanced Care Products) 
1999 3 terbinafine hydrochloride, cimetidine 
suspension, naproxen 
sodium/pseudoephedrine 
Lamisil AT (Novartis), Tagamet HB 200 
(GlaxoSmithKline), Aleve Cold & Sinus 
(Bayer Consumer Care) 
2000 2 docosanol, famotidine/calcium 
carbonate/magnesium hydroxide 
Abreva Cream (Avanir Pharmaceuticals), 
Pepcid Complete (J&J/Merck) 
2001 1 butenafine hydrochloride Lotrimin Ultra (Schering-Plough) 
2002 5 ibuprofen/pseudoephedrine suspension, 
guaifenesin extended-release tablet, 
nicotine polacrilex troche/lozenge, 
loratadine, loratadine/pseudoephedrine 
Children’s Advil Cold (Wyeth), Mucinex 
(Adams Respiratory Therapeutics), Commit 
(GlaxoSmithKline), Claritin (Schering-
Plough), Claritin-D (Schering-Plough) 
2003 1 omeprazole magnesium Prilosec OTC (Procter & Gamble) 
2004 2 guaifenesin/dextromethorphan, 
guaifenesin/pseudoephedrine 
Mucinex DM (Adams Respiratory 
Therapeutics), Mucinex D (Adams 
Respiratory Therapeutics) 
2005 1 diphenhydramine citrate or 
hydrochloride/ibuprofen 
Advil PM (Wyeth) 
2006 4 ecamsule (sunscreen), levonorgestrel, 
polyethylene glycol 3350, ketotifen 
Anthelios SX (L’Oreal), Plan B (Duramed), 
MiraLAX (Schering-Plough), Zaditor 
(Novartis) 
2007 3 orlistat, cetirizine/pseudoephedrine, 
cetirizine 
alli (GlaxoSmithKline), Zyrtec-D (McNeil), 
Zyrtec (McNeil) 
2008 0   
2009 3 lansoprazole, levonorgestrel, 
omeprazole/sodium bicarbonate 
Prevacid 24 HR (Novartis), Plan B One Step 
(Schering-Plough), Zegerid OTC (Schering-
Plough) 
2010 1 ibuprofen/phenylephrine Advil Congestion Relief (Pfizer) 
2011 2 fexofenadine, 
fexofenadine/pseudoephedrine 
Allegra (Chattem) 
Allegra D (Chattem) 
2012 0   
2013 2 oxybutynin transdermal system, 
triamcinolone acetonide 
Oxytrol for Women (Merck), Nasacort 
Allergy 24 HR (Sanofi) 
 
